FDA NDC Directory · JSON-LD · Markdown

Bexarotene

NDC 0378-6955 · HUMAN PRESCRIPTION DRUG · CAPSULE, LIQUID FILLED

Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203174
Dosage form / routeCAPSULE, LIQUID FILLED · ORAL
Active ingredientsBEXAROTENE (75 mg/1)
Marketing started20150709
Package count1

External sources

Source: openFDA. Public-domain (CC0).